I have a topic for discussion we can change to. Ho
Post# of 155001
(Total Views: 749)
Posted On: 09/27/2020 12:44:35 AM
I have a topic for discussion we can change to. How about the Long Hauler study and the implications that it brings in helping the Long Haulers. Think about how big this group is internationally. Dr. K said that 75-87% of hospital admitted people become Long Haulers. This group is going to be huge going forward.
Also what it has brought forward in the knowledge that Leronlimab is reducing the brain fog of the LH group? They figured out that it is crossing the blood brain barrier. This is huge Finding. Dr. K said this brings forward the reason that Neurological diseases have benefit from Leronlimab and also wasn’t it mentioned that what Dr. Patterson has believed in the mechanism of action isn’t fully realized yet when it comes to positive immune modulation and the reason Leronlimab seems to work for so many indications. Not to limit it to Rantes only that positive immune Modulation isn’t fully understood yet.
We have so much information from that last interview we haven’t even touched on yet. When Nader says we have maybe the greatest immediate future of any company going forward. He is talking about these new findings and what they mean for us.
Yet we bicker over conspiracy theories instead of attacking the meat of our boards knowledge about the science of what we just found out. There is some great knowledge here on this board. There has been some real positive findings recently and we are missing the discussions we should be having.
How about we talk the science of Long Haulers?
How about we figure the market and value of the Long Haulers? Maybe they never get over Covid? I hope this can’t be true but what if... Maybe they are long term customers like HIV? We have a study and hopefully it has multiple doses to see if it can prevent the lingering effects of Covid for some time. What the real long term result will be is for how long?
So let’s hear some opinions on these resent developments and new information for a new direction for Covid patients. This is how we had this board performing in the past. The board has been diluted somewhat with new blood. But in that new blood is new opinions. Lets hear all opinions.
Also what it has brought forward in the knowledge that Leronlimab is reducing the brain fog of the LH group? They figured out that it is crossing the blood brain barrier. This is huge Finding. Dr. K said this brings forward the reason that Neurological diseases have benefit from Leronlimab and also wasn’t it mentioned that what Dr. Patterson has believed in the mechanism of action isn’t fully realized yet when it comes to positive immune modulation and the reason Leronlimab seems to work for so many indications. Not to limit it to Rantes only that positive immune Modulation isn’t fully understood yet.
We have so much information from that last interview we haven’t even touched on yet. When Nader says we have maybe the greatest immediate future of any company going forward. He is talking about these new findings and what they mean for us.
Yet we bicker over conspiracy theories instead of attacking the meat of our boards knowledge about the science of what we just found out. There is some great knowledge here on this board. There has been some real positive findings recently and we are missing the discussions we should be having.
How about we talk the science of Long Haulers?
How about we figure the market and value of the Long Haulers? Maybe they never get over Covid? I hope this can’t be true but what if... Maybe they are long term customers like HIV? We have a study and hopefully it has multiple doses to see if it can prevent the lingering effects of Covid for some time. What the real long term result will be is for how long?
So let’s hear some opinions on these resent developments and new information for a new direction for Covid patients. This is how we had this board performing in the past. The board has been diluted somewhat with new blood. But in that new blood is new opinions. Lets hear all opinions.
(4)
(0)